Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
To the Editor: In the CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial reported by Sohns et al. (Oct. 12 issue), 1 patients with end-stage heart failure and atrial fibrillation were randomly assigned to re...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2023-12, Vol.389 (26), p.2495-2497 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2497 |
|---|---|
| container_issue | 26 |
| container_start_page | 2495 |
| container_title | The New England journal of medicine |
| container_volume | 389 |
| creator | Blackwell, Jacob N. Olshansky, Brian Estes, N.A. Mark Kerley, Robert N. Joyce, Emer Sohns, Christian Tijssen, Jan G.P. Sommer, Philipp |
| description | To the Editor:
In the CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial reported by Sohns et al. (Oct. 12 issue),
1
patients with end-stage heart failure and atrial fibrillation were randomly assigned to receive either catheter ablation and medical therapy or medical therapy alone. Previous studies have shown the benefit of ablation for atrial fibrillation in patients with less advanced heart failure.
2
Patients who were candidates for urgent heart transplantation and those who were at high risk for death within 12 months were excluded from the trial. Most patients in . . . |
| doi_str_mv | 10.1056/NEJMc2312887 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2909083706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2906816865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-5c0fd2ea612b7288ef733b7f468504fe3052a7849b0bcd803aedcb2bd871f1f83</originalsourceid><addsrcrecordid>eNqN0btOwzAUBmALgWi5bMwoEgwMBI7jxHbGqkopqMAAzJGd2NRVLsV2hHh7UqUghBg4i5fPv84FoRMMVxgSev2Q3d0XEcER52wHjXFCSBjHQHfRGCDiYcxSMkIHzq2gLxyn-2hEOE5YAukYZVPhl8orG0xkJbxpm8A0QdaU4ZMXryqYK2F9MBOm6qwK3o1fBhNvjaiCmZHWVMOfI7SnReXU8fY9RC-z7Hk6DxePN7fTySIsYuA-TArQZaQExZFkfb9KM0Ik0zHlCcRaEUgiwXicSpBFyYEIVRYykiVnWGPNySG6GHLXtn3rlPN5bVyh-i4a1XYuj1JIgRMG9L-UctbTs1901Xa26QfZKMox5TTp1eWgCts6Z5XO19bUwn7kGPLNJfKfl-j56Ta0k7Uqv_HX6ntwPoC6dnmjVvXfOZ8CfIvz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906816865</pqid></control><display><type>article</type><title>Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation</title><source>New England Journal of Medicine Current</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><creator>Blackwell, Jacob N. ; Olshansky, Brian ; Estes, N.A. Mark ; Kerley, Robert N. ; Joyce, Emer ; Sohns, Christian ; Tijssen, Jan G.P. ; Sommer, Philipp</creator><creatorcontrib>Blackwell, Jacob N. ; Olshansky, Brian ; Estes, N.A. Mark ; Kerley, Robert N. ; Joyce, Emer ; Sohns, Christian ; Tijssen, Jan G.P. ; Sommer, Philipp</creatorcontrib><description>To the Editor:
In the CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial reported by Sohns et al. (Oct. 12 issue),
1
patients with end-stage heart failure and atrial fibrillation were randomly assigned to receive either catheter ablation and medical therapy or medical therapy alone. Previous studies have shown the benefit of ablation for atrial fibrillation in patients with less advanced heart failure.
2
Patients who were candidates for urgent heart transplantation and those who were at high risk for death within 12 months were excluded from the trial. Most patients in . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2312887</identifier><identifier>PMID: 38157509</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Ablation ; Cardiac arrhythmia ; Cardiology ; Catheters ; Clinical medicine ; Clinical practice guidelines ; Conflicts of interest ; Congestive heart failure ; Ejection fraction ; Fibrillation ; Heart failure ; Heart transplantation ; Heart transplants ; Lung transplants ; Mortality ; Patients ; Radiofrequency ablation</subject><ispartof>The New England journal of medicine, 2023-12, Vol.389 (26), p.2495-2497</ispartof><rights>Copyright © 2023 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c408t-5c0fd2ea612b7288ef733b7f468504fe3052a7849b0bcd803aedcb2bd871f1f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2312887$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2906816865?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38157509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blackwell, Jacob N.</creatorcontrib><creatorcontrib>Olshansky, Brian</creatorcontrib><creatorcontrib>Estes, N.A. Mark</creatorcontrib><creatorcontrib>Kerley, Robert N.</creatorcontrib><creatorcontrib>Joyce, Emer</creatorcontrib><creatorcontrib>Sohns, Christian</creatorcontrib><creatorcontrib>Tijssen, Jan G.P.</creatorcontrib><creatorcontrib>Sommer, Philipp</creatorcontrib><title>Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor:
In the CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial reported by Sohns et al. (Oct. 12 issue),
1
patients with end-stage heart failure and atrial fibrillation were randomly assigned to receive either catheter ablation and medical therapy or medical therapy alone. Previous studies have shown the benefit of ablation for atrial fibrillation in patients with less advanced heart failure.
2
Patients who were candidates for urgent heart transplantation and those who were at high risk for death within 12 months were excluded from the trial. Most patients in . . .</description><subject>Ablation</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Catheters</subject><subject>Clinical medicine</subject><subject>Clinical practice guidelines</subject><subject>Conflicts of interest</subject><subject>Congestive heart failure</subject><subject>Ejection fraction</subject><subject>Fibrillation</subject><subject>Heart failure</subject><subject>Heart transplantation</subject><subject>Heart transplants</subject><subject>Lung transplants</subject><subject>Mortality</subject><subject>Patients</subject><subject>Radiofrequency ablation</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0btOwzAUBmALgWi5bMwoEgwMBI7jxHbGqkopqMAAzJGd2NRVLsV2hHh7UqUghBg4i5fPv84FoRMMVxgSev2Q3d0XEcER52wHjXFCSBjHQHfRGCDiYcxSMkIHzq2gLxyn-2hEOE5YAukYZVPhl8orG0xkJbxpm8A0QdaU4ZMXryqYK2F9MBOm6qwK3o1fBhNvjaiCmZHWVMOfI7SnReXU8fY9RC-z7Hk6DxePN7fTySIsYuA-TArQZaQExZFkfb9KM0Ik0zHlCcRaEUgiwXicSpBFyYEIVRYykiVnWGPNySG6GHLXtn3rlPN5bVyh-i4a1XYuj1JIgRMG9L-UctbTs1901Xa26QfZKMox5TTp1eWgCts6Z5XO19bUwn7kGPLNJfKfl-j56Ta0k7Uqv_HX6ntwPoC6dnmjVvXfOZ8CfIvz</recordid><startdate>20231228</startdate><enddate>20231228</enddate><creator>Blackwell, Jacob N.</creator><creator>Olshansky, Brian</creator><creator>Estes, N.A. Mark</creator><creator>Kerley, Robert N.</creator><creator>Joyce, Emer</creator><creator>Sohns, Christian</creator><creator>Tijssen, Jan G.P.</creator><creator>Sommer, Philipp</creator><general>Massachusetts Medical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20231228</creationdate><title>Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation</title><author>Blackwell, Jacob N. ; Olshansky, Brian ; Estes, N.A. Mark ; Kerley, Robert N. ; Joyce, Emer ; Sohns, Christian ; Tijssen, Jan G.P. ; Sommer, Philipp</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-5c0fd2ea612b7288ef733b7f468504fe3052a7849b0bcd803aedcb2bd871f1f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ablation</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Catheters</topic><topic>Clinical medicine</topic><topic>Clinical practice guidelines</topic><topic>Conflicts of interest</topic><topic>Congestive heart failure</topic><topic>Ejection fraction</topic><topic>Fibrillation</topic><topic>Heart failure</topic><topic>Heart transplantation</topic><topic>Heart transplants</topic><topic>Lung transplants</topic><topic>Mortality</topic><topic>Patients</topic><topic>Radiofrequency ablation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blackwell, Jacob N.</creatorcontrib><creatorcontrib>Olshansky, Brian</creatorcontrib><creatorcontrib>Estes, N.A. Mark</creatorcontrib><creatorcontrib>Kerley, Robert N.</creatorcontrib><creatorcontrib>Joyce, Emer</creatorcontrib><creatorcontrib>Sohns, Christian</creatorcontrib><creatorcontrib>Tijssen, Jan G.P.</creatorcontrib><creatorcontrib>Sommer, Philipp</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blackwell, Jacob N.</au><au>Olshansky, Brian</au><au>Estes, N.A. Mark</au><au>Kerley, Robert N.</au><au>Joyce, Emer</au><au>Sohns, Christian</au><au>Tijssen, Jan G.P.</au><au>Sommer, Philipp</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2023-12-28</date><risdate>2023</risdate><volume>389</volume><issue>26</issue><spage>2495</spage><epage>2497</epage><pages>2495-2497</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
In the CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial reported by Sohns et al. (Oct. 12 issue),
1
patients with end-stage heart failure and atrial fibrillation were randomly assigned to receive either catheter ablation and medical therapy or medical therapy alone. Previous studies have shown the benefit of ablation for atrial fibrillation in patients with less advanced heart failure.
2
Patients who were candidates for urgent heart transplantation and those who were at high risk for death within 12 months were excluded from the trial. Most patients in . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>38157509</pmid><doi>10.1056/NEJMc2312887</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2023-12, Vol.389 (26), p.2495-2497 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2909083706 |
| source | New England Journal of Medicine Current; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland |
| subjects | Ablation Cardiac arrhythmia Cardiology Catheters Clinical medicine Clinical practice guidelines Conflicts of interest Congestive heart failure Ejection fraction Fibrillation Heart failure Heart transplantation Heart transplants Lung transplants Mortality Patients Radiofrequency ablation |
| title | Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A13%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catheter%20Ablation%20in%20End-Stage%20Heart%20Failure%20with%20Atrial%20Fibrillation&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Blackwell,%20Jacob%20N.&rft.date=2023-12-28&rft.volume=389&rft.issue=26&rft.spage=2495&rft.epage=2497&rft.pages=2495-2497&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2312887&rft_dat=%3Cproquest_cross%3E2906816865%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906816865&rft_id=info:pmid/38157509&rfr_iscdi=true |